CVEvulnerability
CVE-2020-14525
3.5 LOW
Official page ↗
- Status
- Modified
- Published
- 2020-09-18
- Last modified
- 2026-06-17
- Assigner
- [email protected]
- CVSS 3.1 ([email protected])
- 3.5 LOW — CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
- CVSS 3.1 ([email protected])
- 3.5 LOW — CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
- CVSS 2.0 ([email protected])
- 2.7 LOW — AV:A/AC:L/Au:S/C:P/I:N/A:N
- Weaknesses
- CWE-83
Description
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input
before it is placed in output used as a webpage that is served to other
users.
Affected configurations
• philips clinical collaboration platform (<= 12.2.1)
Related
Weakness · CWE (1)
- CWE-83 Improper Neutralization of Script in Attributes in a Web Page weakness
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01 Third Party Advisory, US Government Resource
- https://www.philips.com/a-w/security/security-advisories/product-security-2020.html#2020_archive www.philips.com
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01 Third Party Advisory, US Government Resource